Ganga Pharmaceuticals

9.91
-1.09
(-9.91%)
Market Cap
8.92 Cr
EPS
0.11
PE Ratio
488.20
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
27.10
52 Week low
10.92
PB Ratio
0.83
Debt to Equity
0.25
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,683.45 4,03,916.05 34.10 49,887.20 12.06 9,648 13.77 52.67
5,620.45 1,49,205.29 72.77 8,184.00 0.89 1,600 64.53 45.57
1,461.90 1,18,065.10 23.53 26,520.70 14.17 4,155 47.38 52.92
3,056.05 1,03,430.62 56.27 10,785.70 11.59 1,656 13.54 47.23
1,107.95 92,448.55 17.17 28,905.40 12.36 5,578 1.69 30.37
2,201.15 90,812.16 43.84 10,615.60 19.57 1,942 -16.38 35.15
1,968.45 89,800.21 31.28 20,141.50 19.94 1,936 38.82 43.62
883.10 88,860.52 19.73 19,831.50 13.82 3,831 29.92 40.81
1,094.75 63,583.26 18.24 29,559.20 17.55 3,169 -10.04 43.94
29,597.00 62,891.56 47.49 6,097.20 10.80 1,201 16.01 49.75
Growth Rate
Revenue Growth
3.45 %
Net Income Growth
18.60 %
Cash Flow Change
-3,050.00 %
ROE
-8.33 %
ROCE
-17.78 %
EBITDA Margin (Avg.)
-4.86 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
3
3
3
3
4
3
3
3
3
3
2
Expenses
2
2
3
3
3
3
2
2
3
3
1
EBITDA
0
0
1
1
1
1
0
0
0
0
0
Operating Profit %
9 %
12 %
10 %
11 %
12 %
13 %
1 %
2 %
0 %
2 %
-2 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
0
0
0
0
0
0
0
0
0
0
EPS in ₹
0.00
0.12
0.18
0.23
0.46
0.46
0.05
0.09
0.10
0.11
0.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
5
7
8
8
8
8
8
8
8
9
Fixed Assets
1
1
1
1
1
1
1
1
1
1
Current Assets
2
5
4
5
4
4
5
5
5
6
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
5
7
7
7
7
7
7
7
7
8
Total Liabilities
5
7
8
8
8
8
8
8
8
9
Current Liabilities
1
1
2
2
2
2
2
2
2
1
Non Current Liabilities
2
1
1
1
1
1
1
1
1
0
Total Equity
3
5
5
5
5
5
5
5
6
7
Reserve & Surplus
0
1
1
1
1
1
1
1
1
2
Share Capital
2
4
4
4
4
4
4
4
4
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
-0
-0
-0
0
0
0
0
Investing Activities
-0
-1
1
-0
0
0
0
0
1
0
Operating Activities
0
-1
0
0
0
-0
-0
-0
0
-1
Financing Activities
-0
2
-0
-0
-0
-0
-0
0
-0
1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Sept 2024
Promoter
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
56.02 %
56.02 %
56.02 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
32.11 %
32.11 %
32.30 %
32.30 %
32.50 %
32.30 %
31.91 %
31.91 %
31.91 %
35.23 %
35.40 %
35.23 %
Others
1.18 %
1.18 %
0.98 %
0.98 %
0.79 %
0.98 %
1.38 %
1.38 %
1.38 %
8.75 %
8.58 %
8.75 %
No of Share Holders
354
354
354
354
356
356
355
356
359
362
363
365

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 08, 2025, 12:34
Statement Of Deviation For September 30, 2024
Nov 08, 2024, 17:36
Un-Audited Financial Results Of The Company For The HalfYear Ended On September 30, 2024.
Nov 08, 2024, 17:31
Board Meeting Outcome for For The Meeting Held On Friday, November 08, 2024
Nov 08, 2024, 17:27
Board Meeting Intimation For Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024
Nov 06, 2024, 15:50
Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024
Nov 05, 2024, 18:33
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 09, 2024, 18:51
Closure of Trading Window
Sep 26, 2024, 19:34
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 25, 2024, 19:12
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 25, 2024, 19:08
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 03, 2024, 14:02
Reg. 34 (1) Annual Report.
Sep 02, 2024, 19:16
Notice Of The 35Th Annual General Meeting Of The Company
Sep 02, 2024, 19:05
Book Closure For The Purpose Of 35Th AGM 2024
Aug 07, 2024, 17:47
Intimation For 35Th Annual General Meeting Scheduled To Be Held On Wednesday, September 25, 2024
Aug 07, 2024, 17:33
Board Meeting Outcome for For The Meeting Held On Wednesday, August 07, 2024
Aug 07, 2024, 17:29
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 04, 2024, 13:10
Submission Of Revised Audited Financial Results For The Half And Financial Year Ended March 31, 2024.
Jun 17, 2024, 18:58
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 29, 2024, 14:42
Announcement under Regulation 30 (LODR)-Investor Presentation
May 16, 2024, 18:55
Statement Of Deviation For March 31, 2024
May 16, 2024, 18:08
Board Meeting Outcome for Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024.
May 16, 2024, 17:19
Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024.
May 16, 2024, 17:13
Board Meeting Intimation for To Inter Alia, Consider And Approve The Audited Financial Results Of The Company For The Half And Financial Year Ended March 31, 2024.
May 06, 2024, 14:46
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Apr 25, 2024, 12:50
Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024
Apr 11, 2024, 19:21
Compliance Certificate Issued Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024
Apr 06, 2024, 18:31
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Apr 06, 2024, 18:24
Closure of Trading Window
Mar 28, 2024, 15:02
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Feb 07, 2024, 17:25
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Feb 07, 2024, 15:18
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Feb 07, 2024, 10:38
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Feb 07, 2024, 10:37
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Jan 27, 2024, 11:15
Announcement under Regulation 30 (LODR)-Allotment
Jan 19, 2024, 18:43
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jan 10, 2024, 15:34
Shareholder Meeting / Postal Ballot-Scrutinizers Report
Jan 04, 2024, 18:12
Shareholder Meeting / Postal Ballot-Outcome of EGM
Jan 04, 2024, 15:47
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dec 13, 2023, 12:41
Extra-Ordinary General Meeting ('EGM') Of The Members Of Ganga Pharmaceuticals Limited Is Scheduled To Be Held OnThursday, January 04, 2024 At 2.30 P.M.
Dec 12, 2023, 13:18
Revised Outcome For The Board Meeting Held On December 04, 2023
Dec 04, 2023, 22:34
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, December 04, 2023
Dec 04, 2023, 19:25
Closure of Trading Window
Nov 27, 2023, 15:22
Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015,
Nov 27, 2023, 15:18
Board Meeting Outcome for Held On Wednesday November 08, 2023
Nov 08, 2023, 12:27
Outcome Of The Board Meeting Pursuant To Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Wednesday, November 08, 2023
Nov 08, 2023, 12:22
Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2023
Oct 28, 2023, 20:09
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 05, 2023, 18:19
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Oct 03, 2023, 10:31
Closure of Trading Window
Sep 29, 2023, 12:59

Technical Indicators

RSI(14)
Neutral
31.53
ATR(14)
Less Volatile
2.01
STOCH(9,6)
Oversold
14.64
STOCH RSI(14)
Oversold
2.18
MACD(12,26)
Bearish
-0.91
ADX(14)
Strong Trend
37.78
UO(9)
Bearish
41.99
ROC(12)
Downtrend And Accelerating
-37.00
WillR(14)
Oversold
-99.89